INOVIO PHARMACEUTICALS, INC. Files 8-K
Ticker: INO · Form: 8-K · Filed: 2026-04-06T07:03:10-04:00
Sentiment: neutral
Topics: material-agreement, filing
TL;DR
INOVIO PHARMACEUTICALS, INC. signed a new deal, check the 8-K for details.
AI Summary
On April 2, 2026, INOVIO PHARMACEUTICALS, INC. entered into a material definitive agreement. The filing also includes other events and financial statements/exhibits related to this report.
Why It Matters
This 8-K filing indicates a significant new agreement for INOVIO PHARMACEUTICALS, INC., which could impact its future operations and financial performance.
Risk Assessment
Risk Level: medium — Material definitive agreements can introduce new risks or opportunities that are not yet fully understood.
Key Players & Entities
- INOVIO PHARMACEUTICALS, INC. (company) — Filer of the 8-K
- 0001055726 (company) — CIK number for INOVIO PHARMACEUTICALS, INC.
- 2026-04-02 (date) — Period of report and date of material definitive agreement
- 2026-04-06 (date) — Filing date and acceptance date of the 8-K
FAQ
What is the nature of the material definitive agreement entered into by INOVIO PHARMACEUTICALS, INC. on April 2, 2026?
The filing indicates Item 1.01: Entry into a Material Definitive Agreement, but the specific details of the agreement are not provided in the summary text.
What other events are reported in this 8-K filing?
The filing includes Item 8.01: Other Events, alongside the material definitive agreement.
Are financial statements included in this filing?
Yes, Item 9.01: Financial Statements and Exhibits indicates that financial statements and exhibits are part of this filing.
What is the CIK number for INOVIO PHARMACEUTICALS, INC.?
The CIK number for INOVIO PHARMACEUTICALS, INC. is 0001055726.
When was this 8-K filing accepted by the SEC?
This 8-K filing was accepted by the SEC on April 6, 2026.
From the Filing
EDGAR Filing Documents for 0001193125-26-142885 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 8-K - Current report: SEC Accession No. 0001193125-26-142885 Filing Date 2026-04-06 Accepted 2026-04-06 07:03:10 Documents 21 Period of Report 2026-04-02 Items Item 1.01: Entry into a Material Definitive Agreement Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits Interactive Data Document Format Files Seq Description Document Type Size 1 8-K d137120d8k.htm iXBRL 8-K 38846 2 EX-1.1 d137120dex11.htm EX-1.1 205277 3 EX-4.1 d137120dex41.htm EX-4.1 78729 4 EX-4.2 d137120dex42.htm EX-4.2 86210 5 EX-4.3 d137120dex43.htm EX-4.3 84504 6 EX-5.1 d137120dex51.htm EX-5.1 16055 7 EX-99.1 d137120dex991.htm EX-99.1 7512 8 EX-99.2 d137120dex992.htm EX-99.2 8187 12 GRAPHIC g137120g0403033514346.jpg GRAPHIC 3629 13 GRAPHIC g137120g0403034717551.jpg GRAPHIC 6354 14 GRAPHIC g137120g0403034900874.jpg GRAPHIC 6309 Complete submission text file 0001193125-26-142885.txt 808305 Data Files Seq Description Document Type Size 9 XBRL TAXONOMY EXTENSION SCHEMA ino-20260402.xsd EX-101.SCH 2829 10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ino-20260402_lab.xml EX-101.LAB 17991 11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ino-20260402_pre.xml EX-101.PRE 11247 24 EXTRACTED XBRL INSTANCE DOCUMENT d137120d8k_htm.xml XML 3642 Mailing Address 660 W. GERMANTOWN PIKE SUITE 110 PLYMOUTH MEETING PA 19462 Business Address 660 W. GERMANTOWN PIKE SUITE 110 PLYMOUTH MEETING PA 19462 8584103134 INOVIO PHARMACEUTICALS, INC. (Filer) CIK : 0001055726 (see all company filings) EIN. : 330969592 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-14888 | Film No.: 26839545 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)